Altera Corp (ALTR) Tops Q4 EPS by 3c

Altera Corp (NASDAQ: ALTR) reported Q4 EPS of $0.45, $0.03 better than the analyst estimate of $0.42. Revenue for the quarter came in at $457.8 million versus the consensus estimate of $447.51 million.

For earnings history and earnings-related data on Altera Corp (ALTR) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
• Aeroflex Holdings (ARX) Tops Q2 EPS by 15c
• Zenas BioPharma, Inc. (ZBIO) Reports Q2 Loss of $1.77